BiotechTube
Aufbau Medical

Aufbau Medical

Dublin, Ireland· Est.
aufbauholdings.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Aufbau Holdings is a private, likely pre-revenue biotechnology company based in Dublin, Ireland, founded in 2016. The company is pivoting from its initial focus on orthopedic diagnostics to a broader platform targeting cancer and eye diseases with novel biology, particularly in RNA imaging and therapeutics. Its leadership team combines strong scientific, clinical, and business expertise, positioning it to explore high-value opportunities in oncology and ophthalmology, though its specific pipeline and technology details remain undisclosed.

OncologyOphthalmology

Technology Platform

Novel biology platform for diagnostics and therapeutics, likely centered on RNA-based technologies including an innovative method for imaging small RNAs in biopsy tissue sections.

Opportunities

Large and growing markets in oncology and ophthalmology diagnostics/therapeutics present a significant opportunity.
A novel RNA-based imaging platform could enable highly precise tissue diagnostics for early detection and personalized treatment, a key unmet need.
The convergence of diagnostics and therapeutics (theranostics) offers a potential long-term strategic advantage.

Risk Factors

High technical risk in translating a novel RNA imaging research method into a validated, commercial clinical product.
Strategic pivot from orthopedic devices to biotech introduces execution and focus risks.
As a pre-revenue private company, it faces substantial funding risk and operates in intensely competitive therapeutic areas.

Competitive Landscape

The competitive landscape is formidable, encompassing large diagnostic firms (e.g., Roche, Abbott), major pharma with diagnostic divisions, and numerous startups in precision oncology and gene therapy for ophthalmology. Success will depend on demonstrating superior clinical utility and specificity compared to existing histopathology and molecular diagnostic standards.

More companies in Diagnostics & Precision Medicine →More companies in Ireland →